Mynvax Private
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $12M
Investors
- 10
About Mynvax Private
Founded in 2017 and based in Karnataka, India, Mynvax Private Limited operates as a clinical-stage vaccine biotechnology company. The company was founded by Gautham Nadig and Raghavan Varadarajan. Mynvax develops thermostable vaccines, mainly protein subunit vaccines, to protect against respiratory viral infections and COVID-19. The firm’s lead product is a thermotolerant COVID-19 vaccine formulation.
Who invested in Mynvax Private
10 investors across 4 rounds
See all investors in Mynvax Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mynvax Private
Who invested in Mynvax Private?
Mynvax Private has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mynvax Private raised?
Mynvax Private has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Mynvax Private last raise money?
Mynvax Private's most recent round on record is a Series A, in Mar 2024.
What does Mynvax Private do?
Founded in 2017 and based in Karnataka, India, Mynvax Private Limited operates as a clinical-stage vaccine biotechnology company.
Where is Mynvax Private headquartered?
Mynvax Private is headquartered in Bangalore, India.
Which VCs invest in companies like Mynvax Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mynvax Private's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mynvax Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.